Livzon Pharmaceutical Group Inc.’s Net Profit Rose 0.2% in 2022

Livzon Pharmaceutical Group Inc. (丽珠医药集团股份有限公司) (000513.SZ) reported a net profit of 2 billion yuan in 2022, up 0.2% year-on-year.

Meanwhile, the company posted 12.6 billion yuan in revenue, up 4.7% year-on-year.

At the end of the reporting period, it had 24.9 billion yuan in total assets and 9.9 billion yuan in total liabilities, with a liability-to-asset ratio of 39.9%.